Skip to main content
REPL
NASDAQ Life Sciences

$150M Offering Priced at Premium to Market, Extending Cash Runway After FDA Approval

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$12.632
Mkt Cap
$1.013B
52W Low
$1.5
52W High
$13.9
52W Position info
742% above low
Off High info
9.1% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

REPL has more than doubled off its 52-week low of $1.5.

Summary

Replimune priced a $150 million underwritten offering just three days after securing FDA accelerated approval for TUDRIQEV in advanced melanoma. The deal includes 9.7 million shares at $12.06 and 2.7 million pre-funded warrants at $12.0599, a premium to the $12.63 market price — signaling strong institutional demand. This follows the going concern warning in the June 10-K, where cash was only sufficient into Q1 2027. The raise materially extends the runway to support the commercial launch and ongoing pipeline development. Closing is expected August 11.

Updates

  1. · SEC 4 — Baker Bros. Advisors acquired 2,736,340 pre-funded warrants at $12.0599 each, totaling $33.0 million, in the offering that closed August 11.

  2. · Dow Jones Newswires — Shares jumped 15% to $13.81 after pricing.

At the time of this announcement, REPL was trading at $12.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1B. The 52-week trading range was $1.50 to $13.90. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

REPL - Latest Insights

REPL
Oct 28, 2026, 7:25 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.99
Real-time Price: $19.10 info
Change: +$6.11 (+47%) info
Market Cap: $1.823B info
REPL
Oct 28, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.99
Real-time Price: $19.10 info
Change: +$6.11 (+47%) info
Market Cap: $1.823B info
REPL
Oct 28, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $12.99
Real-time Price: $19.10 info
Change: +$6.11 (+47%) info
Market Cap: $1.823B info
REPL
Aug 14, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $14.80
Real-time Price: $19.10 info
Change: +$4.30 (+29%) info
Market Cap: $1.823B info
REPL
Aug 14, 2026, 8:10 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.98
Real-time Price: $19.10 info
Change: +$4.12 (+28%) info
Market Cap: $1.823B info